title: Comorbid psychopathy is not associated with increased D2 dopamine receptor TaqI A or B gene marker frequencies in incarcerated substance abusers.
authors.affiliation: National Institute on Drug Abuse, Addiction Research Center, Baltimore, MD.
authors.forename: S S
authors.initials: SS
authors.lastname: Smith
authors.forename: J P
authors.initials: JP
authors.lastname: Newman
authors.forename: A
authors.initials: A
authors.lastname: Evans
authors.forename: R
authors.initials: R
authors.lastname: Pickens
authors.forename: J
authors.initials: J
authors.lastname: Wydeven
authors.forename: G R
authors.initials: GR
authors.lastname: Uhl
authors.forename: D B
authors.initials: DB
authors.lastname: Newlin
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D004247:DNA / Q000032:analysis; D015252:Deoxyribonucleases, Type II Site-Specific; D005787:Gene Frequency; D008040:Genetic Linkage; D005819:Genetic Markers; D006801:Humans; D008297:Male; D010554:Personality Disorders / Q000150:complications / Q000235:genetics* / Q000523:psychology; D012150:Polymorphism, Restriction Fragment Length; D011329:Prisoners; D011569:Psychiatric Status Rating Scales; D017448:Receptors, Dopamine D2 / Q000235:genetics*; D019966:Substance-Related Disorders / Q000150:complications / Q000235:genetics* / Q000523:psychology
chemical_list: D005819:Genetic Markers; D017448:Receptors, Dopamine D2; D004247:DNA; D015252:Deoxyribonucleases, Type II Site-Specific; C027046:TCGA-specific type II deoxyribonucleases